Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.4
5.2
Journals
Cancers
Special Issues
Emerging Technologies in Head and Neck Cancer Surgery
share announcement

Emerging Technologies in Head and Neck Cancer Surgery

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 1760

Special Issue Editors

Dr. Filippo Marchi

E-Mail Website
Guest Editor
Department of Internal Medicine and Medical Specialties, University of Genova, 16100 Genova, Italy
Interests: head and neck surgery
Dr. Vittorio Rampinelli

E-Mail Website
Guest Editor
Unit of Otorhinolaryngology—Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiologic Sciences and Public Health, University of Brescia, 25121 Brescia, Italy
Interests: head and neck cancer
Dr. Pierluigi Bonomo

E-Mail Website
Guest Editor
Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
Interests: head and neck cancer; gastrointestinal cancer; radiotherapy; supportive care

Special Issue Information

Dear Colleagues,

This Special Issue focuses on the advent of new technologies in the field of head and neck surgery. The quest for uniform protocols has remained a persistent focus in head and neck surgery. However, individualization has surfaced as an option for tailoring standardized protocols to each individual patient. This adaptability in treatments has long been a staple in medical disciplines and, in recent years, has found its way into surgery.

Recently, innovative tools have been emerging for preoperative and surgical management of head and neck oncologic patients and have contributed to fewer complications and improved surgical accuracy, bringing therapeutic personalization into our routine clinical and surgical practice.

We are pleased to invite you to submit your work to enrich the panorama of cutting-edge advancements. Therefore, in this Special Issue we welcome papers outlining how innovative technologies and novel applications may improve the diagnostic and therapeutic planning for head and neck patients.

Original research articles and reviews are welcome. Research areas may include, but are not limited, to the following fields of interest: innovation in robotic-assisted surgery, minimally invasive endoscopic/microscopic/exoscopic surgery,  virtual surgical planning, the use of artificial intelligence, videomics and radiomics during pre-operative diagnosis, 3D-printed devices, tissue engineering, computer-aided designing, dynamic navigation, high-definition ultrasound, bioendoscopy and novel immunohistochemical markers in pre-operative and definitive diagnosis.

We look forward to receiving your contributions.

Dr. Filippo Marchi
Dr. Vittorio Rampinelli
Dr. Pierluigi Bonomo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • head and neck cancer
  • robotics
  • 3D printing
  • computer-assisted surgery
  • virtual surgical planning
  • videomics
  • radiomics
  • artificial intelligence
  • early detection
  • minimally invasive surgery

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

15 pages, 1840 KiB  
Article
Transoral Robotic Surgery for Oral Cancer: Evaluating Surgical Outcomes in the Presence of Trismus
by Ting-Shen Lin, Ci-Wen Luo, Tsai-Ling Hsieh, Frank Cheau-Feng Lin and Stella Chin-Shaw Tsai
Cancers 2024, 16(6), 1111; https://doi.org/10.3390/cancers16061111 - 10 Mar 2024
Viewed by 833
Abstract
Trismus, defined as restricted mouth opening, is a common complication among Taiwanese oral cancer patients, especially those who chew betel quid. However, the impact of trismus on survival outcomes in oral cancer patients undergoing transoral robotic surgery (TORS) is unclear. This study aimed [...] Read more.
Trismus, defined as restricted mouth opening, is a common complication among Taiwanese oral cancer patients, especially those who chew betel quid. However, the impact of trismus on survival outcomes in oral cancer patients undergoing transoral robotic surgery (TORS) is unclear. This study aimed to investigate the associations between trismus and surgical outcomes in Taiwanese male oral cancer patients treated with TORS. We conducted a retrospective propensity score-matched cohort study of 40 Taiwanese male oral cancer patients who underwent TORS between 2016 and 2022. Overall, 20 patients with trismus were matched to 20 patients without trismus. TORS achieved similar operative and short-term clinical outcomes in trismus patients to non-trismus patients. There were no significant differences between groups in operation time, blood loss, margin status, flap reconstruction rates, duration of nasogastric tube feeding, or length of hospital stay. Kaplan–Meier and Cox proportional hazard regression analyses were performed to compare overall survival (OS) and disease-free survival (DFS) between the two groups. The overall survival (OS) rate at three years was significantly lower in patients with trismus than those without trismus (27.1% vs. 95.0%, log-rank p = 0.02). However, there was no significant difference in disease-free survival (DFS) rates between the trismus and non-trismus groups (36.6% vs. 62.7%, log-rank p = 0.87). After adjusting for confounders, trismus was independently associated with a 13-fold increased risk of mortality (adjusted HR 12.87, 95% CI 1.55–106.50, p < 0.05). In conclusion, trismus appears to be an independent prognostic factor for reduced long-term OS in Taiwanese male oral cancer patients undergoing TORS, though short-term surgical outcomes were non-inferior in the trismus patients. Further research is warranted to clarify the mechanisms linking trismus and survival in this population. Full article
(This article belongs to the Special Issue Emerging Technologies in Head and Neck Cancer Surgery)
►▼ Show Figures

Figure 1

13 pages, 4235 KiB  
Article
Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical Experience
by Khaled Dibs, Emile Gogineni, Sachin M. Jhawar, Sujith Baliga, John C. Grecula, Darrion L. Mitchell, Joshua Palmer, Karl Haglund, Therese Youssef Andraos, Wesley Zoller, Ashlee Ewing, Marcelo Bonomi, Priyanka Bhateja, Gabriel Tinoco, David Liebner, James W. Rocco, Matthew Old, Mauricio E. Gamez, Arnab Chakravarti, David J. Konieczkowski and Dukagjin M. Blakajadd Show full author list remove Hide full author list
Cancers 2024, 16(4), 688; https://doi.org/10.3390/cancers16040688 - 6 Feb 2024
Viewed by 678
Abstract
Background and purpose: A bolus is required when treating scalp lesions with photon radiation therapy. Traditional bolus materials face several issues, including air gaps and setup difficulty due to irregular, convex scalp geometry. A 3D-milled bolus is custom-formed to match individual patient anatomy, [...] Read more.
Background and purpose: A bolus is required when treating scalp lesions with photon radiation therapy. Traditional bolus materials face several issues, including air gaps and setup difficulty due to irregular, convex scalp geometry. A 3D-milled bolus is custom-formed to match individual patient anatomy, allowing improved dose coverage and homogeneity. Here, we describe the creation process of a 3D-milled bolus and report the outcomes for patients with scalp malignancies treated with Volumetric Modulated Arc Therapy (VMAT) utilizing a 3D-milled bolus. Materials and methods: Twenty-two patients treated from 2016 to 2022 using a 3D-milled bolus and VMAT were included. Histologies included squamous cell carcinoma (n = 14, 64%) and angiosarcoma (n = 8, 36%). A total of 7 (32%) patients were treated in the intact and 15 (68%) in the postoperative setting. The median prescription dose was 66.0 Gy (range: 60.0–69.96). Results: The target included the entire scalp for 8 (36%) patients; in the remaining 14 (64%), the median ratio of planning target volume to scalp volume was 35% (range: 25–90%). The median dose homogeneity index was 1.07 (range: 1.03–1.15). Six (27%) patients experienced acute grade 3 dermatitis and one (5%) patient experienced late grade 3 skin ulceration. With a median follow-up of 21.4 months (range: 4.0–75.4), the 18-month rates of locoregional control and overall survival were 75% and 79%, respectively. Conclusions: To our knowledge, this is the first study to report the clinical outcomes for patients with scalp malignancies treated with the combination of VMAT and a 3D-milled bolus. This technique resulted in favorable clinical outcomes and an acceptable toxicity profile in comparison with historic controls and warrants further investigation in a larger prospective study. Full article
(This article belongs to the Special Issue Emerging Technologies in Head and Neck Cancer Surgery)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop